Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease. - Nakano,Y.; Imagawa,S.; Matsumoto,K.; Stockmann,C.; Obara,N.; Suzuki,N.; Doi,T.; Kodama,T.; Takahashi,S.; Nagasawa,T.; Yamamoto,M. (Blood, 2004)